| Year |
Citation |
Score |
| 2021 |
Guzman-Martinez L, Farías GA, Tapia JP, Sánchez MP, Fuentes P, Gloger S, Maccioni RB. Interventional Study to Evaluate the Clinical Effects and Safety of the Nutraceutical Compound BrainUp-10® in a Cohort of Patients with Alzheimer's Disease: A Multicenter, Randomized, Double-Blind, and Placebo-Controlled Trial. Journal of Alzheimer's Disease : Jad. 81: 1231-1241. PMID 33935080 DOI: 10.3233/JAD-201501 |
0.529 |
|
| 2019 |
Guzman-Martinez L, Maccioni RB, Farías GA, Fuentes P, Navarrete LP. Biomarkers for Alzheimer´s disease. Current Alzheimer Research. PMID 31099321 DOI: 10.2174/1567205016666190517121140 |
0.598 |
|
| 2016 |
Albala C, Angel B, Lera L, Sanchez H, Marquez C, Fuentes P. Low Leptin Availability as a Risk Factor for Dementia in Chilean Older People. Dementia and Geriatric Cognitive Disorders Extra. 6: 295-302. PMID 27504118 DOI: 10.1159/000447447 |
0.337 |
|
| 2015 |
Albala C, Fuentes P, Lera L, Sanchez H, Angel B, Marquez C. P-054: The increasing burden of dementia in Chile European Geriatric Medicine. 6. DOI: 10.1016/S1878-7649(15)30157-1 |
0.327 |
|
| 2014 |
Fuentes P, Albala C. An update on aging and dementia in Chile. Dementia & Neuropsychologia. 8: 317-322. PMID 29213920 DOI: 10.1590/S1980-57642014Dn84000003 |
0.343 |
|
| 2012 |
Fuentes P. Clinical diagnosis in preclinical stage of Alzheimer's disease. Archives of Medical Research. 43: 667-70. PMID 23131824 DOI: 10.1016/J.Arcmed.2012.10.014 |
0.356 |
|
| 2012 |
Carrasco-Gallardo C, FarÃas GA, Fuentes P, Crespo F, Maccioni RB. Can nutraceuticals prevent Alzheimer's disease? Potential therapeutic role of a formulation containing shilajit and complex B vitamins. Archives of Medical Research. 43: 699-704. PMID 23131823 DOI: 10.1016/J.Arcmed.2012.10.010 |
0.561 |
|
| 2011 |
Antón Álvarez X, Fuentes P. Cerebrolysin in Alzheimer's disease. Drugs of Today (Barcelona, Spain : 1998). 47: 487-513. PMID 22013558 DOI: 10.1358/dot.2011.47.7.1656496 |
0.38 |
|
| 2008 |
Sekler A, Jiménez JM, Rojo L, Pastene E, Fuentes P, Slachevsky A, Maccioni RB. Cognitive impairment and Alzheimer's disease: Links with oxidative stress and cholesterol metabolism. Neuropsychiatric Disease and Treatment. 4: 715-22. PMID 19043515 DOI: 10.2147/Ndt.S3268 |
0.588 |
|
| 2008 |
Lavados M, Guillón M, Mujica MC, Rojo LE, Fuentes P, Maccioni RB. Mild cognitive impairment and Alzheimer patients display different levels of redox-active CSF iron. Journal of Alzheimer's Disease : Jad. 13: 225-32. PMID 18376063 DOI: 10.3233/Jad-2008-13211 |
0.568 |
|
| 2006 |
Maccioni RB, Lavados M, Guillón M, Mujica C, Bosch R, FarÃas G, Fuentes P. Anomalously phosphorylated tau and Abeta fragments in the CSF correlates with cognitive impairment in MCI subjects. Neurobiology of Aging. 27: 237-44. PMID 16399209 DOI: 10.1016/J.Neurobiolaging.2005.01.011 |
0.604 |
|
| 2005 |
Fuentes P, Slachevsky A, Reyes P, Cartier L. [Frontotemporal dementia non familial and generalized epilepsy]. Arquivos De Neuro-Psiquiatria. 63: 1016-20. PMID 16400422 DOI: 10.1590/S0004-282X2005000600020 |
0.356 |
|
| 2005 |
Fuentes P, Slachevsky A. [An update on the pharmacological treatment of Alzheimer disease]. Revista Medica De Chile. 133: 224-30. PMID 15824834 |
0.329 |
|
| 2005 |
Von Bernhardi R, Alarcón R, Mezzano D, Fuentes P, Inestrosa NC. Blood cells cholinesterase activity in early stage Alzheimer's disease and vascular dementia Dementia and Geriatric Cognitive Disorders. 19: 204-212. PMID 15677868 DOI: 10.1159/000083500 |
0.428 |
|
| Show low-probability matches. |